Congress tossed states a curveball whenever it legalized CBD.
05/31/2019 05:18 PM EDT
Federal regulators’ murky response to the quick legalization regarding the hemp extract CBD has generated a patchwork of state responses — ranging from broadly permissive to raids on retailers and seizures of trailers full of profitable leaf. At a gathering Friday, Food And Drug Administration panelists asked pharmaceutical businesses and client businesses whether or not the extensive accessibility to off-the-shelf CBD items — including pet meals to epidermis natural oils touted as salves for several kinds of disorders — had an impression on efforts to analyze and develop cannabis-based medications. But organizations that are looking to make use of CBD as medication countered that federal red tape is what’s holding up progress on developing medications. Read more